Porcine Epidemic Diarrhea Vaccines Industry Growth Expected to Reach $2.42 Billion by 2029 at a CAGR of 7.6% | Segmentation and Growth Opportunities
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has the Porcine Epidemic Diarrhea Vaccines Market Growth Performance Trended Historically, And What Lies Ahead?_x000D_
The market size for porcine epidemic diarrhea vaccines has seen robust growth in the past few years. The market is predicted to increase from $1.67 billion in 2024 to $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. This growth in the historical timeframe can be credited to extensive vaccination drives, widened immunization programs (EPI), the utilization of disposable syringes, efforts to eradicate diarrhea, and endeavors such as the global alliance for vaccines and immunization (GAVI)._x000D_
_x000D_
#What Is the Forecast for the Porcine Epidemic Diarrhea Vaccines Market Size Through 2029?#_x000D_
In the coming years, the market for porcine epidemic diarrhea vaccines is expected to witness significant growth, with an estimated worth of $2.42 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.6%. Factors contributing to this growth trend foreseeably include the increasing emphasis on vaccination programs, advanced vaccine development pathways, growing pig populations globally, prioritization of cold chain management, and heightened awareness about preventive health strategies. The upcoming trends consist of continual advancements in vaccine delivery device technology, a growing focus on needle-less solutions, improvements in personalized medicine, a rising inclination towards self-vaccination, and reinforcing of the animal health infrastructure and distribution networks._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp_x000D_
_x000D_
#What are the Key Market Players in Porcine Epidemic Diarrhea Vaccines Market and How They’re Evolving?#_x000D_
Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Santé Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd., IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc_x000D_
_x000D_
#What Are the Primary Growth Drivers in the Porcine Epidemic Diarrhea Vaccines Market?#_x000D_
The surge in pig farming is expected to fuel the expansion of the porcine epidemic diarrhea vaccine market. This kind of farming involves the raising of domestic pigs for meat, breeding, rearing from birth to market weight, and selling pork products. The escalation in pig farming is driven by the incrementing global demand for pork, enhancements in breeding and management practices, technological advancements in farming methodologies, and the growth of markets for pork consumption. Vaccines for porcine epidemic diarrhea (PED) play a crucial role in pig farming to mitigate and control outbreaks. These vaccines are typically administered through injection or orally, beginning from the sow’s gestation period to pass on immunity to newborn piglets via colostrum. For instance, 2022 recorded a pork production of 40.6 billion pounds in the United States, representing a 1 percent rise from the preceding year, as documented by the United States Department of Agriculture, a US governmental department. As a result, the surge in pig farming is stimulating the expansion of the porcine epidemic diarrhea vaccine market._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=16514&type=smp_x000D_
_x000D_
#What Are the Leading Segments in the Global Porcine Epidemic Diarrhea Vaccines Industry?#_x000D_
The porcine epidemic diarrhea vaccines market covered in this report is segmented –_x000D_
_x000D_
1) By Product: Live Vaccines, Killed Vaccines_x000D_
2) By Application: Piglets, Adults Pigs_x000D_
3) By End-User: Veterinary Hospitals, Hog Production Farms_x000D_
_x000D_
Subsegments:_x000D_
1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines_x000D_
2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines_x000D_
_x000D_
#What Are the Key Market Trends in the Porcine Epidemic Diarrhea Vaccines Industry?#_x000D_
Leading firms in the porcine epidemic diarrhea vaccines market are enhancing their market presence through the introduction of cutting-edge products like the Porcine Parvovirus (PPV) vaccine. Designed as a veterinary inoculation, the PPV vaccine plays a critical role in mitigating the risk of reproductive failure in pigs triggered by PPV – a minor, non-enveloped virus which is linked to infertility, stillbirths, mummified fetuses, and frail piglets. To illustrate, Boehringer Ingelheim, a German pharmaceutical enterprise, rolled out the ReproCyc ParvoFLEX porcine parvovirus (PPV) vaccine in March 2022. The newly released vaccine aims to tackle the reproductive failure in pigs, particularly the infertility, stillbirths, mummified fetuses, and weak piglets associated with PPV, a minor, non-enveloped virus. The launch stands out due to its advanced formulation and the effectiveness of the vaccine. It allows a broad-spectrum cover against PPV-induced reproductive losses, hence ensuring the health and productivity of pig herds are sustained._x000D_
_x000D_
#Access The Full Report Here:#_x000D_
_x000D_
#What Is the Regional Outlook for the Porcine Epidemic Diarrhea Vaccines Market?#_x000D_
Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Purchase The Full Report Today:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16514_x000D_
_x000D_
#This Report Delivers Insight On: #_x000D_
1. How big is the porcine epidemic diarrhea vaccines market, and how is it changing globally?_x000D_
2. Who are the major companies in the porcine epidemic diarrhea vaccines market, and how are they performing?_x000D_
3. What are the key opportunities and risks in the porcine epidemic diarrhea vaccines market right now?_x000D_
4. Which products or customer segments are growing the most in the porcine epidemic diarrhea vaccines market?_x000D_
5. What factors are helping or slowing down the growth of the porcine epidemic diarrhea vaccines market?_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 2071930708_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
